These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
120 related items for PubMed ID: 8337029
1. Effectiveness and safety of an Haemophilus influenzae type b conjugate vaccine (PRP-T) in young infants. Kaiser-UCLA Vaccine Study Group. Vadheim CM, Greenberg DP, Partridge S, Jing J, Ward JI. Pediatrics; 1993 Aug; 92(2):272-9. PubMed ID: 8337029 [Abstract] [Full Text] [Related]
2. Safety and immunogenicity of PRP-T combined with DTP: excretion of capsular polysaccharide and antibody response in the immediate post-vaccination period. Miller MA, Meschievitz CK, Ballanco GA, Daum RS. Pediatrics; 1995 Apr; 95(4):522-7. PubMed ID: 7700752 [Abstract] [Full Text] [Related]
3. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants. Punjabi NH, Richie EL, Simanjuntak CH, Harjanto SJ, Wangsasaputra F, Arjoso S, Rofiq A, Prijanto M, Julitasari, Yela U, Herzog C, Cryz SJ. Vaccine; 2006 Mar 10; 24(11):1776-85. PubMed ID: 16303216 [Abstract] [Full Text] [Related]
5. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants. Chotpitayasunondh T, Panpitpat C, Thisyakorn U, Furer E, Que JU, Hasler T, Cryz SJ. Southeast Asian J Trop Med Public Health; 1997 Mar 10; 28(1):91-8. PubMed ID: 9322290 [Abstract] [Full Text] [Related]
9. Randomized trial to assess immunogenicity and safety of Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine in infants. Marchant CD, Miller JM, Marshall GS, Blatter M, Aris E, Friedland LR, Boutriau D, HibMenCY-TT 005 Study Group. Pediatr Infect Dis J; 2010 Jan 10; 29(1):48-52. PubMed ID: 20035207 [Abstract] [Full Text] [Related]
10. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine. Panpitpat C, Thisyakorn U, Chotpitayasunondh T, Fürer E, Que JU, Hasler T, Cryz SJ. Bull World Health Organ; 2000 Jan 10; 78(3):364-71. PubMed ID: 10812736 [Abstract] [Full Text] [Related]
18. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content. Hla KH, Thein SA, Aye A, Han HH, Bock HL, David MP, Schuerman L. Pediatr Infect Dis J; 2006 Aug 10; 25(8):706-12. PubMed ID: 16874170 [Abstract] [Full Text] [Related]
19. One-year post-primary antibody persistence and booster immune response to a fully liquid five-component acellular pertussis, diphtheria, tetanus, inactivated poliomyelitis, Haemophilus influenzae type b conjugate vaccine. Lin TY, Wang YH, Huang YC, Chiu CH, Lin PY, Chen CJ, Chavand P, Ortiz E. Int J Infect Dis; 2007 Nov 10; 11(6):488-95. PubMed ID: 17349809 [Abstract] [Full Text] [Related]